Differing effects of low-dose estrogen–progestin therapy and pravastatin in postmenopausal hypercholesterolemic women

By Davis S. R.   Goldstat R.   Newman A.   Berry K.   Burger H. G.   Meredith I.   Koch K.  

Climacteric, Vol. 5, Iss. 4, 2002-12 ,pp. : 341-350

Informa Healthcare

Access to resources Recommend Favorite

Transition to raloxifene with and without low-dose estrogen therapy in postmenopausal women: effects on serum lipids and fibrinogen - a pilot study

By O'Neill S. M.   Eden J.   Baber R.   Ekangaki A.   Stocks J. M.   Wolthers T.   Davis S. R.  

Climacteric, Vol. 6, Iss. 4, 2003-12 ,pp. : 347-353

Informa Healthcare

Access to resources Recommend Favorite

Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus

By Araújo D. A. C.   Farias M. L. F.   Andrade A. T. L.  

Climacteric, Vol. 5, Iss. 3, 2002-09 ,pp. : 286-292

Informa Healthcare

Access to resources Recommend Favorite

Low-dose intravaginal estradiol delivery using a Silastic vaginal ring for estrogen replacement therapy in postmenopausal women: a review

By Sarkar N. N.  

The European Journal of Contraception and Reproductive Health Care, Vol. 8, Iss. 4, 2003-12 ,pp. : 217-224

Informa Healthcare

Access to resources Recommend Favorite

Effects of oral and transdermal low-dose estrogen therapy on echocardiographic parameters of cardiac function

By Vogelvang T.E.   van der Mooren M.J.   Kamp O.   Mijatovic V.   Visser C.A.   Kenemans P.  

Fertility and Sterility, Vol. 80, Iss. 3, 2003-09 ,pp. : 546-553

Elsevier

Access to resources Recommend Favorite